Improving survival from metastatic, recurrent, or persistent cervical cancer
Details
Publication Year 2024-01-06,Volume 403,Issue #10421,Page 2-4
Journal Title
Lancet
Publication Type
Commentary
Publisher
Elsevier
Keywords
Female; Humans; *Uterine Cervical Neoplasms/drug therapy; Bevacizumab/therapeutic use; Paclitaxel/therapeutic use; Neoplasm Recurrence, Local/drug therapy; Antineoplastic Combined Chemotherapy Protocols
Department(s)
Medical Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-02-20 12:41:05
Last Modified: 2024-02-22 12:34:29
An error has occurred. This application may no longer respond until reloaded. Reload 🗙